Transdermal progesterone cream for vasomotor symptoms and postmenopausal bone loss.

Authors: Leonetti HB, Longo S, Anasti JN. Publication Year: 1999 Citation: Obstet Gynecol 1999;94(2):225-8. In this randomized controlled trial, 102 menopausal women were treated with topical progesterone (Pro-gest®, 20 mg daily) or placebo and monitored for 1 year. Improvement in vasomotor symptoms was seen in 83% of the women in the treatment group who had …

Part 2 – The science behind bioidentical hormone replacement therapy.

Author: Wepfer ST Publication Year: 2002 Citation: Int J Pharm Compounding 2002;6(1):50-54 The author describes the differences between natural progesterone and the synthetic progestin medroxyprogesterone acetate (MPA), saying that the number 1 problem in women’s health care today is a lack of understanding about progesterone and a belief that it is the same thing as MPA. …